Vaginal insert for cervical lesions trial halted early

NCT ID NCT05502367

Terminated Disease control Sponsor: Antiva Biosciences Source: ClinicalTrials.gov ↗

First seen Mar 11, 2026 · Last updated May 18, 2026 · Updated 7 times

Summary

This study tested a vaginal insert called ABI-2280 in women with cervical precancerous lesions. The goal was to see if it was safe and could help clear the abnormal cells. The trial was stopped early, so results are limited. It involved 44 women aged 25 to 55 who used the insert themselves.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Botho ke Bontle Health Services

Waltloo, Gauteng, 0184, South Africa
CerviCusco

Cusco, Peru
East Sydney Doctors

Darlinghurst, New South Wales, 2010, Australia
Farmovs

Bloemfontein, Free State, 9301, South Africa
Ginobs S.A.

Lima, Peru
Gole Biomedical Research Centre

Ga-Mothapo, Limpopo, South Africa
Nafasi Integrated Solutions

Sunnyside, Gauteng, 0002, South Africa

Conditions

Explore the condition pages connected to this study.

CERVICAL INTRAEPITHELIAL NEOPLASIA